[1] Lv T, Li M, Zeng N, Zhang J, et al. Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population. J Gastroenterol Hepatol, 2019,34:1676-1684. [2] Tansel A, Katz LH, El-Serag HB, et al. Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol, 2017, 15:1207-1217.e4. [3] Wong RJ, Gish R, Frederick T, et al. Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series. Dig Dis Sci, 2011, 56:578-585. [4] Nakano M, Fukami T, Nakajima M. Adenosine deaminases acting on RNA downregulate the expression of constitutive androstane receptor in the human liver-derived cells by attenuating splicing. J Pharmacol Exp Ther, 2019, 370:408-415. [5] Dangana EO, Michael OS, Omolekulo TE, et al. Enhanced hepatic glycogen synthesis and suppressed adenosine deaminase activity by lithium attenuates hepatic triglyceride accumulation in nicotine-exposed rats. Biomed Pharmacother, 2019, 109:1417-1427. [6] Baldissera MD, Bottari NB, Mendes RE, et al. Activity of cholinesterases, pyruvate kinase and adenosine deaminase in rats experimentally infected by fasciola hepatica: influences of these enzymes on inflammatory response and pathological findings. Pathol Res Pract, 2015, 211:871-876. [7] 彭小燕, 徐莉娟, 刘鹏, 等. 自身免疫性肝炎患者血清腺苷脱氨酶水平与肝组织炎症活动程度的关系及对治疗应答的影响. 实用肝脏病杂志, 2019, 22:200-203. [8] 宋岩, 杨虎, 林琳, 等. 白蛋白-胆红素评分在自身免疫性肝炎肝硬化预后评估中的应用. 中华肝脏病杂志, 2019, 27:772-776. [9] 黄云丽, 单晶, 黄春洋, 等. 老年自身免疫性肝炎患者的临床特征及自身抗体水平. 中华老年多器官疾病杂志, 2019, 18:16-20. [10] 曹丽丽, 张敏, 朱世殊, 等. 儿童自身免疫性肝炎46例临床病理特点及疗效分析. 中华儿科杂志, 2019, 57:40-45. [11] 陈曦, 李志艳, 车辚, 等. 自身免疫性肝炎患者的超声表现与病理及实验室检查的相关性分析. 中华医学超声杂志(电子版), 2018, 15:263-267. [12] Torgutalp M, Efe C, Babaoglu H. Relationship between serum adenosine deaminase levels and liver histology in autoimmune hepatitis. World J Gastroenterol, 2017, 23:3876-3882. [13] 杨炜炜. 自身免疫性肝炎患者血清腺苷脱氨酶水平与肝组织学的关系. 肝脏, 2018, 23:614-617. [14] 周哲, 周璐, 张玉洁, 等. 瞬时弹性成像在自身免疫性肝炎纤维化早期诊断中的价值及影响因素. 中华消化杂志, 2018, 38:344-346. [15] Bombaci M, Pesce E, Torri A, et al. Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms. Liver Int, 2019. 39:2124-2135. |